Copyright © 1989 by the European Society of Cardiology.
© 1989 The European Society of Cardiology
Long-term survival in medically treated patients with ischemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study ODI)
Received 15 March 1988; revised 5 October 1988; .
Address for correspondence: Prof. A. L'Abbate, CNR Clinical Physiology Institute, via Savi 8, 56100 Pisa, Italy.
Abstract
In order to study long-term survival in medically treated patients with ischaemic heart disease in our country and to evaluate the prognostic significance of clinical variables, 1083 patients less than 65 years old were followed up for a mean period of 66 months (min 36, max 93). All patients performed an exercise stress test and had coronary angiography. Vital status was known for 98.3% of the patients. The great majority were treated with calcium antagonists and nitrates. In the overall population, the annual cardiac mortality rate was 1.54%. On the basis of clinical variables, groups with a tenfold difference in mortality could be identified. The annual cardiac mortality was 0.29% in patients without myocardial infarction and effort ischaemia and reached 3.12% in those with extensive infarction and/or severe reduction of exercise tolerance. Among risk factors, only arterial hypertension was an independent predictor of mortality. According to angiographic variables, the highest mortality rate was 5.7% in patients with three-vessel disease and poor left ventricular function. When multivariate analysis was applied to clinically stratified subgroups, angiographic variables gave additional prognostic information on survival only in the subgroup with an intermediate prognosis. In conclusion (1) the annual cardiac mortality in our medically treated patients is low; (2) patients with very different prognoses may be identified on a clinical basis; (3) coronary angiography adds prognostic information only in moderately severe disease.
Key Words: Prognosis ischaemic heart disease medical treatment clinical variables
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF] |
||||
![]() |
M. Tendera Editorial: If inhibition: from pure heart reduction to treatment of stable angina Eur. Heart J. Suppl., September 1, 2005; 7(suppl_H): H3 - H6. [Full Text] [PDF] |
||||
![]() |
J. L Eastaugh, M. J Calvert, and N. Freemantle Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients Fam. Pract., February 1, 2005; 22(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Bonetti, C. Kaiser, M. J. Zellweger, L. Grize, P. Erne, R. A. Schoenenberger, M. E. Pfisterer, and TIME Investigators Long-Term Benefits and Limitations of Combined Antianginal Drug Therapy in Elderly Patients with Symptomatic Chronic Coronary Artery Disease Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 29 - 37. [Abstract] [PDF] |
||||
![]() |
R. Florenciano-Sanchez, J. A. Castillo-Moreno, E. Molina-Laborda, M. Jimenez-Pascual, P. Garcia-Urruticoechea, S. Egea-Beneyto, J. G. Sanchez-Villanueva, and J. Ortega-Bernal The exercise test that indicates a low risk of events: Differences in prognostic significance between patients with chronic stable angina and patients with unstable angina J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1974 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Williams, S. D. Fihn, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Diagnosis and Risk Stratification Ann Intern Med, October 2, 2001; 135(7): 530 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prakash, J. Myers, V. F. Froelicher, R. Marcus, D. Do, D. Kalisetti, and J. E. Atwood Clinical and Exercise Test Predictors of All-Cause Mortality : Results From > 6,000 Consecutive Referred Male Patients Chest, September 1, 2001; 120(3): 1003 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Nishime, C. R. Cole, E. H. Blackstone, F. J. Pashkow, and M. S. Lauer Heart Rate Recovery and Treadmill Exercise Score as Predictors of Mortality in Patients Referred for Exercise ECG JAMA, September 20, 2000; 284(11): 1392 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Forslund, P Hjemdahl, C Held, I Bjorkander, S.V Eriksson, U Brodin, and N Rehnqvist Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from The Angina Prognosis Study In Stockholm (APSIS) Eur. Heart J., June 1, 2000; 21(11): 901 - 910. [Abstract] [PDF] |
||||
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
![]() |
K. M. Kuntz, K. E. Fleischmann, M. G.M. Hunink, and P. S. Douglas Cost-Effectiveness of Diagnostic Strategies for Patients with Chest Pain Ann Intern Med, May 4, 1999; 130(9): 709 - 718. [Abstract] [Full Text] [PDF] |
||||







